- Potential benefitImproved diagnostic accuracy and patient safety from standardized facility requirements and trained personnel.
- Potential benefitReduced Medicare fraud and improper billing by limiting payment to accredited facilities.
- Potential benefitLikely fewer unnecessary treatments and repeat tests due to stronger quality assurance and contemporaneous interpretati…
Electrodiagnostic Medicine Patient Protection and Fraud Elimination Act of 2025
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for c…
The bill amends Medicare payment rules to require that, beginning between three and four years after enactment, Medicare will only pay for nerve conduction studies and needle electromyography tests if those services are furnished at a ‘‘qualified facility’’ (accredited by organizations the Secretary specifies). The Secretary must, within set timelines, specify accrediting organizations, finalize regulations on accreditation and reaccreditation, and establish a National Electrodiagnostic Services Advisory Committee to advise on facility requirements, fraud reduction, and quality.
Supporters emphasize patient protection and fraud reduction
Relative to its intended legislative type, this bill translates a clear policy change (linking Medicare payment to accreditation for electrodiagnostic services) into a mostly concrete legal framework with defined service scope, facility requirements, specification/regulatory deadlines, and an advisory committee.
The bill amends Medicare payment rules to require that, beginning between three and four years after enactment, Medicare will only pay for nerve conduction studies and needle electromyography tests if those services are furnished at a ‘‘qualified facility’’ (accredited by organizations the Secretary specifies).
The Secretary must, within set timelines, specify accrediting organizations, finalize regulations on accreditation and reaccreditation, and establish a National Electrodiagnostic Services Advisory Committee to advise on facility requirements, fraud reduction, and quality.
The rule exempts intraoperative neuromonitoring and requires on-site, at-the-time interpretation and minimum training for providers performing needle electromyography tests.
Reasonable bipartisan appeal on fraud/quality grounds, but regulatory burdens, provider opposition, and Senate procedure lower standalone odds; likeliest as part of a larger package.
Relative to its intended legislative type, this bill translates a clear policy change (linking Medicare payment to accreditation for electrodiagnostic services) into a mostly concrete legal framework with defined service scope, facility requirements, specification/regulatory deadlines, and an advisory committee. It contains useful implementation sequencing but leaves important operational and fiscal details unaddressed.
Supporters emphasize patient protection and fraud reduction
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Potential burdenIncreases regulatory and administrative burden on small clinics seeking accreditation.
- Potential burdenCosts for equipment upgrades and accreditation may force some providers to stop offering services.
- Potential burdenMay reduce access in rural or underserved areas if facilities cannot obtain accreditation.
Why the argument around this bill splits.
Supporters emphasize patient protection and fraud reduction
Likely supportive overall because the bill pursues patient protection, quality assurance, and fraud reduction within Medicare.
May press for safeguards to prevent access harms to low-income, rural, or community providers during implementation.
Cautiously favorable to stronger quality standards and anti-fraud measures, but concerned about implementation costs, provider access, and administrative complexity.
Will seek clearer timelines, cost estimates, and phased implementation.
Likely opposed due to increased federal conditions on Medicare payments, regulatory expansion, and concerns about reduced access and higher costs.
Views the accreditation mandate as federal overreach into clinical practice and private markets.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Reasonable bipartisan appeal on fraud/quality grounds, but regulatory burdens, provider opposition, and Senate procedure lower standalone odds; likeliest as part of a larger package.
- No CBO cost estimate provided
- Provider compliance cost and accreditation capacity unknown
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Supporters emphasize patient protection and fraud reduction
Reasonable bipartisan appeal on fraud/quality grounds, but regulatory burdens, provider opposition, and Senate procedure lower standalone o…
Relative to its intended legislative type, this bill translates a clear policy change (linking Medicare payment to accreditation for electrodiagnostic services) into a mostly concrete legal framework with defined servic…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.